PCAT6 and lung adenocarcinoma: Li et al. reported that knockdown of PCAT6 might be a potential therapeutic strategy for lung adenocarcinoma [17], but further studies on a more detailed understanding of the underlying molecular mechanisms of PCAT6 were needed.